The Dangers of Defective Pharmaceuticals

Posted by on May 12, 2015 in Product Dangers

Millions of patients rely on the pharmaceutical industry to create solutions to their important medical needs. Typically, these solutions help individuals successfully receive treatment and live fuller lives. There are, however, certain moments when pharmaceutical solutions also lead to unforeseen side effects and cause even more hardship and devastation. In fact, these defective pharmaceutical solutions often constitute to a majority of the product liability lawsuits filed in courts all over America.

Despite advancements in the field, there are still some drugs and medications that can cause serious issues for a significant number of patients in the United States. Most of the time, problems with defective pharmaceuticals are missed because of missteps in research and testing. Even when a pharmaceutical product has been approved by the Food and Drug Administration (FDA), there is no certainty that it will be completely safe from side effects.

In most cases, the devastating effects of defective pharmaceuticals are due to mistakes committed by manufacturers. There are several pharmaceutical companies that market certain products for off-label use—treatments that are yet to be explicitly approved by the FDA because of lack of adequate testing. According to the website of Williams Kherkher, one such example is the Stryker hip implant. Another pharmaceutical product often the subject of product liability suits is the anti-psychotic drug called Risperdal. As pointed out by the website of the lawyers of Williams Kherkher, the continued off-label use of the drug has led to several cases of serious medical conditions like gynecomastia and hyperglycemia.

It is a horrifying thought to consider that the products intended to treat patients can cause other medical conditions that could be far more serious than what they originally had. As such, it’s important for affected individuals to seek out legal counsel as soon as possible. The dangers of defective pharmaceuticals should never be ignored. Manufactures should be continuously held accountable for falling short of the high standards require of their profession.

Post a Reply

Your email address will not be published. Required fields are marked *